Type 1 diabetes patients develop clonal hematopoiesis—abnormal blood cell clones—approximately 7 years earlier than healthy individuals, with 4.4% prevalence versus 3.0% in controls among 416,565 UK Biobank participants. Disease duration was independently associated with shorter leukocyte telomeres, cellular aging markers that protect chromosome ends. Critically, shorter telomeres correlated with 37% higher heart attack risk in diabetics. This accelerated hematopoietic aging represents a previously unrecognized mechanism linking diabetes to cardiovascular disease beyond traditional risk factors like cholesterol or blood pressure. The finding suggests diabetes fundamentally alters blood stem cell function, creating a pro-inflammatory environment that damages blood vessels over time. While clonal hematopoiesis didn't directly predict heart attacks in this cohort, telomere attrition emerged as a measurable biomarker for cardiovascular risk stratification. This could enable earlier intervention strategies targeting cellular aging pathways rather than just glucose control. However, as an unreviewed preprint, these results require validation through peer review and replication in diverse populations before clinical application.